What Are the Effects and Benefits of Tongshu Tablets?

Pain-Relieving Tablets (Tongshu Pian) are a traditional Chinese herbal formulation approved by China’s National Medical Products Administration for the symptomatic management of mild-to-moderate musculoskeletal pain. Clinically, they are indicated for conditions such as acute lumbar sprain, cervical spondylosis, osteoarthritis, and soft-tissue contusions—particularly when presenting with localized swelling, tenderness, restricted mobility, or stiffness.

The formula contains five core botanical ingredients: Curcuma wenyujin (Ezhu), Prunus persica seed (Taoren), Carthamus tinctorius (Honghua), Angelica sinensis (Danggui), and Leonurus japonicus (Yimucao). These herbs collectively exert anti-inflammatory, analgesic, and microcirculatory-enhancing effects. Preclinical studies suggest modulation of pro-inflammatory cytokines—including TNF-α, IL-1β, and IL-6—as well as inhibition of cyclooxygenase-2 (COX-2) activity, contributing to reduced peripheral sensitization and edema resolution.

Clinical trials in adults have demonstrated statistically significant improvements in pain intensity (measured by VAS scores), functional limitation (assessed via the Oswestry Disability Index or similar tools), and local signs of inflammation compared with placebo or conventional NSAIDs—though with a more favorable gastrointestinal tolerability profile. Notably, Tongshu Pian is not intended for chronic pain maintenance therapy or as a substitute for disease-modifying interventions in progressive arthropathies.

Contraindications include pregnancy, lactation, active peptic ulcer disease, severe hepatic or renal impairment, and known hypersensitivity to any constituent herb. Potential adverse effects are generally mild and transient, including occasional epigastric discomfort, dizziness, or mild skin rash. As with all herbal medicines, concomitant use with anticoagulants or antiplatelet agents warrants caution due to theoretical additive effects on bleeding risk.